Biora Therapeutics, Inc. has announced its Annual Meeting of Stockholders to be held virtually on June 5, 2024. Stockholders of record as of April 16, 2024, are invited to attend the meeting online, with registration required by June 4. The agenda includes the election of six director nominees to serve until the 2025 Annual Meeting, the ratification of KPMG LLP as the independent auditor for the year ending December 31, 2024, an amendment to increase the number of authorized shares of common stock, and the authorization of share issuance underlying certain warrants in compliance with Nasdaq Listing Rule 5635(d). The Board of Directors recommends a vote in favor of all proposals. Proxy materials are available online, and stockholders may request paper copies until May 24, 2024.

Biora Therapeutics, Inc. has announced its Annual Meeting of Stockholders to be held virtually on June 5, 2024. Stockholders of record as of April 16, 2024, are invited to attend the meeting online, with registration required by June 4. The agenda includes the election of six director nominees to serve until the 2025 Annual Meeting, the ratification of KPMG LLP as the independent auditor for the year ending December 31, 2024, an amendment to increase the number of authorized shares of common stock, and the authorization of share issuance underlying certain warrants in compliance with Nasdaq Listing Rule 5635(d). The Board of Directors recommends a vote in favor of all proposals. Proxy materials are available online, and stockholders may request paper copies until May 24, 2024.